Shiyong Ma

ORCID: 0000-0003-2911-3722
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Phylogenetic Studies
  • Pharmacogenetics and Drug Metabolism
  • Bioinformatics and Genomic Networks
  • Bone and Dental Protein Studies
  • Ferroptosis and cancer prognosis
  • Computational Drug Discovery Methods
  • Gene expression and cancer classification
  • Glioma Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Dental Trauma and Treatments
  • Genetic diversity and population structure
  • Chronic Myeloid Leukemia Treatments
  • Renal cell carcinoma treatment
  • Bone Tissue Engineering Materials
  • Single-cell and spatial transcriptomics
  • Advanced Proteomics Techniques and Applications
  • CRISPR and Genetic Engineering
  • RNA and protein synthesis mechanisms
  • Cancer Genomics and Diagnostics
  • Acute Myeloid Leukemia Research
  • Mitochondrial Function and Pathology
  • Prostate Cancer Treatment and Research
  • Analytical Chemistry and Chromatography
  • Tissue Engineering and Regenerative Medicine
  • Periodontal Regeneration and Treatments

Chongqing Medical University
2022-2024

Johns Hopkins University
2018-2021

Johns Hopkins Medicine
2021

UNSW Sydney
2016-2017

David Clark Saravana M. Dhanasekaran Francesca Petralia Jianbo Pan Xiaoyu Song and 95 more Yingwei Hu Felipe da Veiga Leprevost Boris Reva T. Mamie Lih Hui-Yin Chang Weiping Ma Chen Huang Christopher J. Ricketts Lijun Chen Azra Krek Yize Li Dmitry Rykunov Qing Kay Li Lin S. Chen Umut Özbek Suhas Vasaikar Yige Wu Seungyeul Yoo Shrabanti Chowdhury Matthew A. Wyczalkowski Jiayi Ji Michael Schnaubelt Andy T. Kong Sunantha Sethuraman Dmitry M. Avtonomov Minghui Ao Antonio Colaprico Song Cao Kyung-Cho Cho Selim Kalaycı Shiyong Ma Wenke Liu Kelly V. Ruggles Anna Calinawan Zeynep H. Gümüş Daniel Geiszler Emily Kawaler Guo Ci Teo Bo Wen Yuping Zhang Sarah Keegan Kai Li Feng Chen Nathan Edwards Phillip M. Pierorazio Xi Steven Chen Christian P. Pavlovich A. Ari Hakimi Gabriel Bromiński James J. Hsieh Andrzej Antczak Tatiana Omelchenko Jan Lubiński Maciej Wiznerowicz W. Marston Linehan Christopher R. Kinsinger Mathangi Thiagarajan Emily S. Boja Mehdi Mesri Tara Hiltke Ana I. Robles Henry Rodriguez Jiang Qian David Fenyö Bing Zhang Li Ding Eric E. Schadt Arul M. Chinnaiyan Zhen Zhang Gilbert S. Omenn Marcin Cieślik Daniel W. Chan Alexey I. Nesvizhskii Pei Wang Hui Zhang A. Samad Hashimi Alexander R. Pico Alla Karpova Alyssa Charamut Amanda G. Paulovich Amy M. Perou Anna Malovannaya Annette Marrero-Oliveras Anupriya Agarwal Barbara Hindenach Barbara L. Pruetz Beom‐Jun Kim Brian J. Druker Chelsea J. Newton Chet Birger Corbin D. Jones Cristina E. Tognon D.R. Mani Dana R. Valley Daniel C. Rohrer

To elucidate the deregulated functional modules that drive clear cell renal carcinoma (ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and phosphoproteomic characterization of treatment-naive ccRCC paired normal adjacent tissue samples. Genomic analyses identified a distinct molecular subgroup associated with genomic instability. Integration proteogenomic measurements uniquely protein dysregulation cellular mechanisms impacted by alterations, including...

10.1016/j.cell.2019.10.007 article EN cc-by Cell 2019-10-01

We developed OmicsMapNet approach to take advantage of existing deep leaning frameworks analyze high-dimensional omics data as 2-dimensional images. The individual samples were first rearranged into 2D images in which molecular features related functions, ontologies, or other relationships organized spatially adjacent and patterned locations. Deep learning neural networks trained classify the Molecular informative classes different phenotypes subsequently identified. As an example, we used...

10.48550/arxiv.1804.05283 preprint EN other-oa arXiv (Cornell University) 2018-01-01

Aberrant stem cell-like gene regulatory networks are a feature of leukaemogenesis. The ETS-related (ERG), an important regulator normal haematopoiesis, is also highly expressed in T-ALL and acute myeloid leukaemia (AML). However, the transcriptional regulation ERG leukaemic cells remains poorly understood. In order to discover regulators ERG, we employed quantitative mass spectrometry-based method identify factors binding 321 bp +85 cell enhancer region MOLT-4 KG-1 AML cells. Using this...

10.1093/nar/gkw804 article EN cc-by-nc Nucleic Acids Research 2016-09-06

Current PSA-based tests used to detect prostate cancer (PCa) lack sufficient specificity, leading significant overdetection and overtreatment. Our previous studies showed that serum fucosylated PSA (Fuc-PSA) soluble TEK receptor tyrosine kinase (Tie-2) had the ability predict aggressive (AG) PCa. Additional biomarkers are needed address this clinical problem.

10.7150/thno.55676 article EN cc-by Theranostics 2021-01-01

Human-treated dentin matrix (hTDM) has recently been studied as a natural extracellular matrix-based biomaterial for pulp regeneration. However, porcine-treated (pTDM) is potential alternative scaffold due to limited availability. there dearth of information regarding the protein composition and underlying molecular mechanisms pTDM.Methods: hTDM pTDM were fabricated using human porcine teeth, respectively, their morphological characteristics examined scanning electron microscopy. Stem cells...

10.1016/j.mtbio.2024.100990 article EN cc-by-nc-nd Materials Today Bio 2024-02-05

// Shiyong Ma 1 , Ranjeeta Menon 1, 2 Rebecca C. Poulos and Jason W.H. Wong Prince of Wales Clinical School, Faculty Medicine, UNSW Sydney, Australia Present address: Centre for Research Excellence in Tuberculosis the Marie Bashir Institute Infectious Diseases Biosecurity, The University Sydney Microbiology – Public Health, Westmead Hospital, NSW, Correspondence to: Wong, email: jason.wong@unsw.edu.au Keywords: Proteogenomics; phosphoproteomics; RNA-seq; Jurkat; splicing factor mutation...

10.18632/oncotarget.21339 article EN Oncotarget 2017-09-27

Drug-likeness is a vital consideration when selecting compounds in the early stage of drug discovery. A series drug-like properties are needed to predict drug-likeness given compound and provide useful guidelines increase likelihood converting lead into drugs. Experimental physicochemical properties, pharmacokinetic/toxicokinetic maximum dosages approved small-molecule drugs from multiple text-based unstructured data resources have been manually assembled, curated, further digitized...

10.1093/database/baab083 article EN cc-by Database 2022-01-01

Genetically modified organisms (GMOs) can be generated to model human genetic disease or plant resistance, and they have contributed the exploration understanding of gene function, physiology, onset drug target discovery. Here, PertOrg (http://www.inbirg.com/pertorg/) was introduced provide multilevel alterations in GMOs. Raw data 58 707 transcriptome profiles associated information, such as phenotypic alterations, were collected curated from studies involving vivo perturbation (e.g....

10.1093/nar/gkac872 article EN cc-by-nc Nucleic Acids Research 2022-09-28

10.1007/978-1-4939-6740-7_11 article EN Methods in molecular biology 2016-12-14

BackgroundMost studies used animal serum-containing medium for bioengineered-root regeneration, but ethical and safety issues raised by serum are a potentially significant risk clinical use. Thus, this study aimed to find safer method regeneration.MethodsThe biological properties of human dental pulp stem cells (hDPSCs) cultured in component-free (ACF) or (5%, 10% medium, SCM) were compared vitro. hDPSCs three-dimensional (3D) environment with human-treated dentin matrix (hTDM). The capacity...

10.1016/j.heliyon.2024.e34173 article EN cc-by-nc-nd Heliyon 2024-07-01

Abstract Background Diffuse intrinsic pontine gliomas (DIPGs) and other H3K27M-mutated diffuse midline (DMGs) are brain tumors that primarily affect children. Radiotherapy is the standard of care but only provides temporary symptomatic relief due to radioresistance. Although hypoxia a major driver radioresistance in tumors, there no definitive evidence DIPGs hypoxic. often contain histone mutations, which alter tumor metabolism also associated with Our objective was identify metabolic...

10.1093/neuonc/noae255 article EN cc-by-nc Neuro-Oncology 2024-11-22
Coming Soon ...